Table 1 Description of cohort outcomes and demographics
From: Data-driven prediction of continuous renal replacement therapy survival
UCLA CRRT | Cedars Sinai CRRT | UCLA Control | ||||||
|---|---|---|---|---|---|---|---|---|
Overall | Do not recommend | Recommend | Overall | Do not recommend | Recommend | Do not recommend | ||
n | 4161 | 1920 | 2241 | 3263 | 1462 | 1801 | 1562 | |
Outcome, n (%) | ||||||||
Comfort Care | 1179 (28.3) | 1179 (61.4) | - | 984 (30.2) | 984 (67.3) | - | - | |
Expired | 741 (17.8) | 741 (38.6) | - | 478 (14.6) | 478 (32.7) | - | 242 (15.5) | |
Recovered renal function | 602 (14.5) | - | 602 (26.9) | 704 (21.6) | - | 704 (39.1) | - | |
Transitioned to hemodialysis | 1639 (39.4) | - | 1639 (73.1) | 1097 (33.6) | - | 1097 (60.9) | - | |
Total days on CRRT, median [Q1, Q3] | 6.0 [3.0,12.0] | 5.0 [2.0,12.0] | 6.0 [3.0,12.0] | 5.0 [3.0,10.0] | 4.0 [2.0,9.0] | 6.0 [4.0,11.0] | 0.0 [0.0,0.0] | |
Year of CRRT, median [min, max] | 2018 [2015,2021] | 2018 [2015,2021] | 2018 [2015,2021] | 2019 [2016,2021] | 2019 [2016,2021] | 2019 [2016,2021] | 2019 [2016,2021] | |
Number of previous CRRT Treatments, mean (SD) | 0.2 (0.7) | 0.1 (0.5) | 0.3 (0.8) | 0.2 (0.5) | 0.1 (0.4) | 0.2 (0.5) | 0.0 (0.0) | |
Age, median [Q1, Q3] | 60.0 [47.0,69.0] | 60.0 [48.0,69.0] | 59.0 [45.0,68.0] | 66.0 [56.0,75.0] | 68.0 [58.0,78.0] | 63.0 [53.0,73.0] | 61.0 [48.0,70.0] | |
Sex, n (%) | ||||||||
Female | 1682 (40.4) | 765 (39.8) | 917 (40.9) | 1111 (36.3) | 537 (37.8) | 574 (35.0) | 627 (40.1) | |
Male | 2479 (59.6) | 1155 (60.2) | 1324 (59.1) | 1946 (63.7) | 882 (62.2) | 1064 (65.0) | 935 (59.9) | |
Ethnicity, n (%) | ||||||||
Hispanic or Latino | 1416 (34.0) | 580 (30.2) | 836 (37.3) | 756 (24.7) | 307 (21.6) | 449 (27.4) | 548 (35.1) | |
Not Hispanic or Latino | 2745 (66.0) | 1340 (69.8) | 1405 (62.7) | 2301 (75.3) | 1112 (78.4) | 1189 (72.6) | 1014 (64.9) | |
Race, n (%) | ||||||||
American Indian or Alaska Native | 15 (0.4) | 11 (0.6) | 4 (0.2) | 4 (0.1) | 1 (0.1) | 3 (0.2) | 30 (1.9) | |
Asian | 337 (8.1) | 163 (8.5) | 174 (7.8) | 249 (8.1) | 103 (7.3) | 146 (8.9) | 131 (8.4) | |
Black or African American | 429 (10.3) | 199 (10.4) | 230 (10.3) | 462 (15.1) | 226 (15.9) | 236 (14.4) | 158 (10.1) | |
Multiple Races | 42 (1.0) | 15 (0.8) | 27 (1.2) | 115 (3.8) | 40 (2.8) | 75 (4.6) | 25 (1.6) | |
Native Hawaiian or Other Pacific Islander | 21 (0.5) | 10 (0.5) | 11 (0.5) | 12 (0.4) | 3 (0.2) | 9 (0.5) | 9 (0.6) | |
Unknown | 1268 (30.5) | 555 (28.9) | 713 (31.8) | 500 (16.4) | 287 (20.2) | 213 (13.0) | 591 (37.8) | |
White or Caucasian | 2049 (49.2) | 967 (50.4) | 1082 (48.3) | 1715 (56.1) | 759 (53.5) | 956 (58.4) | 618 (39.6) | |
Heart comorbidities, n (%) | ||||||||
No | 1115 (26.8) | 516 (26.9) | 599 (26.7) | 584 (17.9) | 189 (12.9) | 395 (21.9) | 1074 (68.8) | |
Yes | 3046 (73.2) | 1404 (73.1) | 1642 (73.3) | 2679 (82.1) | 1273 (87.1) | 1406 (78.1) | 488 (31.2) | |
Liver comorbidities, n (%) | ||||||||
No | 1159 (27.9) | 532 (27.7) | 627 (28.0) | 1353 (41.5) | 528 (36.1) | 825 (45.8) | 1220 (78.1) | |
Yes | 3002 (72.1) | 1388 (72.3) | 1614 (72.0) | 1910 (58.5) | 934 (63.9) | 976 (54.2) | 342 (21.9) | |
Infection comorbidities, n (%) | ||||||||
No | 1709 (41.1) | 821 (42.8) | 888 (39.6) | 925 (28.3) | 291 (19.9) | 634 (35.2) | 1334 (85.4) | |
Yes | 2452 (58.9) | 1099 (57.2) | 1353 (60.4) | 2338 (71.7) | 1171 (80.1) | 1167 (64.8) | 228 (14.6) | |
Other comorbidities, n (%) | ||||||||
No | 3925 (94.3) | 1831 (95.4) | 2094 (93.4) | 3142 (96.3) | 1423 (97.3) | 1719 (95.4) | 1315 (84.2) | |
Yes | 236 (5.7) | 89 (4.6) | 147 (6.6) | 121 (3.7) | 39 (2.7) | 82 (4.6) | 247 (15.8) | |
